Compare Biogen Inc (BIIB) vs Colgate-Palmolive Company (CL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Colgate-Palmolive Company — how do they compare? Biogen Inc trades at $203.5 (market cap $30.13B), while Colgate-Palmolive Company trades at $92.3 (market cap $73.59B). The key difference: Colgate-Palmolive Company is far larger — about 2.4× Biogen Inc's market cap, and Colgate-Palmolive Company pays a 2.3% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | CL | |
|---|---|---|
Market Cap | $30.13B | $73.59B |
Sector | Health | Consumer Staples |
52-Week High | $216.63 | $99.14 |
52-Week Low | $128.93 | $74.98 |
Enterprise Value | $37.20B | $80.07B |
Dividend Yield | — | 2.3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →
